ResMed Inc.

RMD Healthcare Medical Instruments & Supplies

ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025. In the quarter to June 2026, revenue grew 8.58%, EPS grew 2.32%, free cash flow fell 21.3% and total debt fell 39.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.

238.97 3.26 −1.35%
Market cap
$34.1B
P/E
22.8×
Fwd P/E
16.6×
Dividend yield
1.03%
F-score
6/9
Altman Z
10.00
Beneish M
−2.59
Dividend safety
96/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
18.63 21.58 23.73 27.90

+8 more quarters

P/S ratio
5.02 5.89 6.51 7.61
P/FCF ratio
17.41 18.79 19.77 22.78
P/Operating CF
62.38 58.88 103.40 87.50
P/B ratio
4.31 5.03 5.56 6.54
Price to Tangible BV
8.80 10.79 12.34 15.21
EV/Sales
4.83 5.66 6.32 7.43
EV/EBITDA
12.81 14.55 16.52 19.67
EV/Operating CF
15.11 16.60 17.82 20.73
EV/FCF
16.76 18.07 19.20 22.22
Quick Ratio
1.80 1.97 1.93 1.82
Current Ratio
3.10 3.01 3.06 2.89
Net Debt/EBITDA
(2.12) (2.21) (1.83) (1.93)
Debt/Assets
4.45% 4.60% 4.75% 4.92%
Debt/Equity
0.06 0.06 0.06 0.07
Asset Turnover
0.66 0.68 0.69 0.68
Operating CF/Net income
1.19 1.39 0.87 1.31
Capex/Depreciation
(1.04) (0.57) (0.55) (0.79)
Interest Coverage
(21.48) (40.68) (61.85) (50.78)
Research and Development Expense of Revenue
7.22% 6.59% 6.39% 6.54%
Selling, General and Administrative Expense of Revenue
20.24% 19.96% 19.57% 19.41%
Intangible Assets out of Total Assets
0.38 0.39 0.41 0.42
Share Based Compensation of Revenue
1.88% 1.87% 2.03% 1.58%
Graham Net Nets
0.07 0.05 0.05 0.04
Graham Number
103.20 102.24 99.49 96.14
Earnings Yield
5.37% 4.63% 4.21% 3.58%
Free Cash Flow Yield
5.74% 5.32% 5.06% 4.39%
Revenue per Share
10.06 9.85 9.76 9.14
Operating CF per Share
3.12 3.81 2.33 3.13
Capex per Share
(0.39) (0.27) (0.24) (0.31)
Free Cash Flow per Share
2.73 3.54 2.09 2.82
Cash per Share
10.10 11.43 9.72 9.47
Shareholders Equity per Share
45.25 44.67 43.34 41.87
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
45.25 44.67 43.34 41.87
Free Cash Flow
397.38 514.54 305.19 411.54
Working Capital
2,929.63 2,712.85 2,570.69 2,370.23
Capital Expenditures
(57.25) (39.59) (34.55) (45.78)
Net Current Asset Value
1,944.18 1,771.69 1,636.31 1,438.65
EV/EBIT
14.46 16.58 18.76 22.38
Capex to Sales
0.04 0.03 0.02 0.03
Price to Operating Income
15.03 17.24 19.31 22.94
Other line items
Average Receivables
987.86 953.33 922.79 859.23
Average Payables
293.54 247.93 235.36 258.03
Average Inventory
936.76 887.26 902.07 931.89
Average Assets
8,570.17 8,175.55 7,822.35 7,765.38
Average Common Equity
6,276.63 6,019.02 5,786.94 5,658.15

Fold the line items

Columns are period end dates